Literature DB >> 28246921

Magnetic resonance imaging features of uterine sarcoma and mimickers.

Matthias Barral1,2,3, Vinciane Placé4, Raphaël Dautry4, Sandra Bendavid4, Françoise Cornelis5, Romain Foucher4,6, Youcef Guerrache4, Philippe Soyer4,6.   

Abstract

Uterine myometrial tumors are predominantly benign conditions that affect one-third of women and represent the main indication for hysterectomy. Preoperative imaging is of utmost importance for characterization and for precise mapping of myometrial tumors to best guide therapeutic strategy. New minimally invasive therapeutic strategies including morcellation, myolysis, uterine artery embolization and image-guided radiofrequency or focused ultrasound ablation have been developed for the treatment of uterine leiomyoma. However, preoperative differentiation between atypical leiomyomas and leiomyosarcomas is critical on imaging as uterine sarcoma requires a specific surgical technique to prevent dissemination. A single, rapidly growing uterine tumor, associated with endometrial thickening and ascites, in post-menopausal women is suspicious of uterine endometrial stromal sarcoma and carcinosarcoma. Suggestive magnetic resonance imaging features have been described, but overlap in imaging appearance between uterine leiomyosarcomas and cellular leiomyomas makes it challenging to ascertain the diagnosis. This review aims to illustrate the imaging features of uterine sarcomas and potential mimickers to make the reader more familiar with this serious condition which needs special consideration.

Entities:  

Keywords:  Diffusion-weighted MRI; Leiomyoma; Leiomyosarcoma; Magnetic resonance imaging (MRI); Uterine sarcoma

Mesh:

Year:  2017        PMID: 28246921     DOI: 10.1007/s00261-017-1076-9

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  17 in total

Review 1.  Updates on Uterine Artery Embolization.

Authors:  Maureen P Kohi; James B Spies
Journal:  Semin Intervent Radiol       Date:  2018-04-05       Impact factor: 1.513

2.  Moving Toward Individualized Medicine for Uterine Leiomyomas.

Authors:  Shannon K Laughlin-Tommaso; Elizabeth A Stewart
Journal:  Obstet Gynecol       Date:  2018-10       Impact factor: 7.661

Review 3.  Advances in the Preoperative Identification of Uterine Sarcoma.

Authors:  Junxiu Liu; Zijie Wang
Journal:  Cancers (Basel)       Date:  2022-07-20       Impact factor: 6.575

4.  Multiparametric MR evaluation of uterine leiomyosarcoma and STUMP versus leiomyoma in symptomatic women planned for high frequency focussed ultrasound: accuracy of imaging parameters and interobserver agreement for identification of malignancy.

Authors:  Parisa Aminzadeh; Ekaterina Alibrahim; Andrew Dobrotwir; Eldho Paul; Stacy Goergen
Journal:  Br J Radiol       Date:  2021-01-28       Impact factor: 3.039

5.  Survey among ESGE members on leiomyosarcoma morcellation incidence.

Authors:  Hans Brölmann; Rudi Leon DeWilde; Peter O'Donovan; Elina Symeonidou; Rudi Campo; Vasilios Tanos
Journal:  Gynecol Surg       Date:  2017-12-04

Review 6.  Role of surgery in gynaecological sarcomas.

Authors:  Valentina Ghirardi; Nicolò Bizzarri; Francesco Guida; Carmine Vascone; Barbara Costantini; Giovanni Scambia; Anna Fagotti
Journal:  Oncotarget       Date:  2019-04-02

7.  Diagnostic interpretation of non-contrast qualitative MR imaging features for characterisation of uterine leiomyosarcoma.

Authors:  Hilal Sahin; Janette Smith; Jeries Paolo Zawaideh; Amreen Shakur; Luca Carmisciano; Iztok Caglic; Annemarie Bruining; Mercedes Jimenez-Linan; Sue Freeman; Helen Addley
Journal:  Br J Radiol       Date:  2021-06-16       Impact factor: 3.629

Review 8.  MRI findings in-between leiomyoma and leiomyosarcoma: a Rad-Path correlation of degenerated leiomyomas and variants.

Authors:  Vlad Bura; Roxana Maria Pintican; Reka Emma David; Helen Clare Addley; Janette Smith; Mercedes Jimenez-Linan; Janice Lee; Susan Freeman; Carmen Georgiu
Journal:  Br J Radiol       Date:  2021-07-21       Impact factor: 3.629

9.  Diagnostic Value of Preoperative CA125, LDH and HE4 for Leiomyosarcoma of the Female Reproductive System.

Authors:  Fenfen Zhang; Yao Liu; Quan Quan; Yu Meng; Xiaoling Mu
Journal:  Cancer Manag Res       Date:  2021-06-14       Impact factor: 3.989

Review 10.  New imaging modalities to distinguish rare uterine mesenchymal cancers from benign uterine lesions.

Authors:  Pamela Causa Andrieu; Sungmin Woo; Tae-Hyung Kim; Elizabeth Kertowidjojo; Anjelica Hodgson; Simon Sun
Journal:  Curr Opin Oncol       Date:  2021-09-01       Impact factor: 3.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.